Omnicell (NASDAQ:OMCL) Upgraded at BidaskClub

Omnicell (NASDAQ:OMCL) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports.

OMCL has been the subject of several other reports. Stephens assumed coverage on Omnicell in a research note on Monday, July 6th. They issued an “overweight” rating and a $90.00 price objective for the company. Craig Hallum decreased their price target on Omnicell from $102.00 to $85.00 and set a “buy” rating for the company in a research note on Wednesday, July 29th. Piper Sandler decreased their price target on Omnicell from $76.00 to $70.00 and set a “neutral” rating for the company in a research note on Wednesday, July 29th. Finally, Cantor Fitzgerald raised their price target on Omnicell from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Omnicell has an average rating of “Buy” and a consensus price target of $85.50.

NASDAQ OMCL opened at $72.81 on Friday. The stock has a market capitalization of $3.06 billion, a PE ratio of 64.43, a P/E/G ratio of 3.22 and a beta of 0.93. Omnicell has a 1-year low of $54.24 and a 1-year high of $94.85. The business has a 50 day simple moving average of $68.79 and a two-hundred day simple moving average of $69.28.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.14. The business had revenue of $199.62 million during the quarter, compared to analyst estimates of $182.16 million. Omnicell had a return on equity of 9.21% and a net margin of 5.42%. The company’s revenue for the quarter was down 8.2% on a year-over-year basis. During the same period last year, the company earned $0.67 EPS. Equities analysts predict that Omnicell will post 1.48 EPS for the current fiscal year.

In other Omnicell news, EVP Scott Peter Seidelmann sold 2,125 shares of Omnicell stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of $67.70, for a total transaction of $143,862.50. Following the completion of the sale, the executive vice president now directly owns 33,385 shares of the company’s stock, valued at approximately $2,260,164.50. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Randall A. Lipps sold 3,718 shares of Omnicell stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $75.15, for a total value of $279,407.70. Following the sale, the chief executive officer now directly owns 152,116 shares of the company’s stock, valued at $11,431,517.40. The disclosure for this sale can be found here. Insiders own 2.63% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Ensign Peak Advisors Inc increased its holdings in shares of Omnicell by 0.6% in the 1st quarter. Ensign Peak Advisors Inc now owns 32,900 shares of the company’s stock valued at $2,158,000 after acquiring an additional 200 shares during the period. Torray LLC increased its holdings in shares of Omnicell by 1.8% in the 2nd quarter. Torray LLC now owns 13,042 shares of the company’s stock valued at $921,000 after acquiring an additional 229 shares during the period. Magnus Financial Group LLC increased its holdings in shares of Omnicell by 7.4% in the 2nd quarter. Magnus Financial Group LLC now owns 3,906 shares of the company’s stock valued at $276,000 after acquiring an additional 268 shares during the period. Meeder Asset Management Inc. increased its holdings in shares of Omnicell by 930.8% in the 1st quarter. Meeder Asset Management Inc. now owns 402 shares of the company’s stock valued at $26,000 after acquiring an additional 363 shares during the period. Finally, Brown Capital Management LLC increased its holdings in shares of Omnicell by 2.6% in the 1st quarter. Brown Capital Management LLC now owns 15,056 shares of the company’s stock valued at $987,000 after acquiring an additional 381 shares during the period. 98.99% of the stock is owned by institutional investors and hedge funds.

About Omnicell

Omnicell, Inc provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.

Further Reading: Return on Investment (ROI) Defined, Explained

Analyst Recommendations for Omnicell (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell and related companies with MarketBeat.com's FREE daily email newsletter.